BGI Genomics Co., Ltd. Stock

Equities

300676

CNE100003449

Biotechnology & Medical Research

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
38.08 CNY -0.96% Intraday chart for BGI Genomics Co., Ltd. -1.45% -20.67%
Sales 2022 7.05B 973M Sales 2023 4.35B 601M Capitalization 19.68B 2.72B
Net income 2022 803M 111M Net income 2023 92M 12.71M EV / Sales 2022 2.13 x
Net cash position 2022 6.21B 858M Net cash position 2023 5.12B 707M EV / Sales 2023 3.35 x
P/E ratio 2022
26.4 x
P/E ratio 2023
213 x
Employees -
Yield 2022
1.93%
Yield 2023
0.21%
Free-Float 51.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.96%
1 week-1.45%
Current month-6.96%
1 month-14.91%
3 months-8.94%
6 months-23.38%
Current year-20.67%
More quotes
1 week
37.76
Extreme 37.76
39.34
1 month
37.76
Extreme 37.76
46.19
Current year
33.00
Extreme 33
48.30
1 year
33.00
Extreme 33
72.33
3 years
33.00
Extreme 33
136.78
5 years
33.00
Extreme 33
199.40
10 years
16.37
Extreme 16.37
261.99
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-06-15
Founder 70 -
Director of Finance/CFO 46 21-06-15
Members of the board TitleAgeSince
Founder 70 -
Director/Board Member - 16-03-28
Director/Board Member 45 -
More insiders
Date Price Change Volume
24-04-19 38.08 -0.96% 2,362,438
24-04-18 38.45 +0.10% 2,842,451
24-04-17 38.41 +1.24% 3,208,250
24-04-16 37.94 -2.77% 2,526,732
24-04-15 39.02 +0.98% 2,429,740

End-of-day quote Shenzhen S.E., April 18, 2024

More quotes
BGI Genomics Co., Ltd. is a leading provider of genomic and proteomic sequencing services primarily to academic institutions, pharmaceutical companies and healthcare providers. The company also provides genomic solutions for biomarker research and development, screening for some of the trisomies present at birth (trisomy 21, trisomy 18 and trisomy 13) and solutions for neo-antigen identification for immuno-oncology research.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300676 Stock